These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38493274)

  • 1. Low-Dose Aspirin Use Does Not Increase Disease Activity in Pregnant Patients with Inflammatory Bowel Disease.
    DeBolt CA; Gottlieb ZS; Rao MG; Johnson S; Rekawek P; Deshpande R; Meislin R; Berkin J; Bianco A; Mella MT; Dubinsky MC
    Dig Dis Sci; 2024 May; 69(5):1803-1807. PubMed ID: 38493274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is low-dose aspirin therapy to prevent preeclampsia more efficacious in non-obese women or when initiated early in pregnancy?
    Cantu JA; Jauk VR; Owen J; Biggio JR; Abramovici AR; Edwards RK; Tita AT
    J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1128-32. PubMed ID: 25048750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Low-Dose Aspirin to Prevent Preeclampsia in Pregnant People with Chronic Hypertension.
    Derrah K; Greiner KS; Rincón M; Burwick RM
    Am J Perinatol; 2024 May; 41(S 01):e974-e980. PubMed ID: 36347504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of low-dose aspirin for prevention of preeclampsia.
    Trivedi NA
    J Postgrad Med; 2011; 57(2):91-5. PubMed ID: 21654128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose aspirin for the prevention of severe preeclampsia in patients with chronic kidney disease: a retrospective study : This is the study for kidney and pregnancy..
    Wang M; Chen S; He Y; Zhao M; Yang H; Chen Q
    J Nephrol; 2021 Oct; 34(5):1631-1639. PubMed ID: 33914255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose aspirin increases 15-epi-lipoxins A
    Gonzalez-Brown VM; Ma'ayeh M; Kniss DA; Cackovic M; Landon MB; Rood KM
    Pregnancy Hypertens; 2021 Dec; 26():75-78. PubMed ID: 34563982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose-aspirin usage among women with an increased preeclampsia risk: A prospective cohort study.
    van Montfort P; Scheepers HCJ; van Dooren IMA; Meertens LJE; Zelis M; Zwaan IM; Spaanderman MEA; Smits LJM
    Acta Obstet Gynecol Scand; 2020 Jul; 99(7):875-883. PubMed ID: 31953956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-bowel mucosal injuries in low-dose aspirin users with obscure gastrointestinal bleeding.
    Iwamoto J; Mizokami Y; Saito Y; Shimokobe K; Honda A; Ikegami T; Matsuzaki Y
    World J Gastroenterol; 2014 Sep; 20(36):13133-8. PubMed ID: 25278707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Universal Screening for Preeclampsia Risk and Aspirin Recommendation in the Ultrasound Unit.
    Pimentel VM; Larrea ADA; Renaud SJ; Sloan S; Figueroa R; Wakefield D; Crowell R
    Am J Perinatol; 2024 May; 41(S 01):e3187-e3195. PubMed ID: 38101442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Henderson JT; Vesco KK; Senger CA; Thomas RG; Redmond N
    JAMA; 2021 Sep; 326(12):1192-1206. PubMed ID: 34581730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated Prevalence of Risk Factors for Preeclampsia Among Individuals Giving Birth in the US in 2019.
    Wheeler SM; Myers SO; Swamy GK; Myers ER
    JAMA Netw Open; 2022 Jan; 5(1):e2142343. PubMed ID: 34982156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension.
    Banala C; Moreno S; Cruz Y; Boelig RC; Saccone G; Berghella V; Schoen CN; Roman A
    Am J Obstet Gynecol; 2020 Sep; 223(3):419.e1-419.e16. PubMed ID: 32173446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia.
    Tolcher MC; Chu DM; Hollier LM; Mastrobattista JM; Racusin DA; Ramin SM; Sangi-Haghpeykar H; Aagaard KM
    Am J Obstet Gynecol; 2017 Sep; 217(3):365.e1-365.e8. PubMed ID: 28455079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Risk of Preeclampsia in Women with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.
    Patel NB; Vinsard DG; Kattah AG; Kane SV
    Dig Dis Sci; 2023 Sep; 68(9):3557-3561. PubMed ID: 37402980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.
    Warlé-van Herwaarden MF; Koffeman AR; Valkhoff VE; 't Jong GW; Kramers C; Sturkenboom MC; De Smet PA
    Br J Clin Pharmacol; 2015 Sep; 80(3):589-98. PubMed ID: 25777983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 20. Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease.
    Tandon P; Lee EY; Maxwell C; Hitz L; Ambrosio L; Dieleman L; Halloran B; Kroeker K; Huang VM
    Dig Dis Sci; 2021 May; 66(5):1639-1649. PubMed ID: 32533542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.